BusinessHorizon Pharma plc Named to the Crain’s Chicago Business 2017 “Best Places To Work” ListBy Nasdaq OMXApr 7, 2017, 12:00 PM UTC
BusinessCytoDyn Announces Investment Community Conference Call for April 18, 2017By Nasdaq OMXApr 6, 2017, 8:13 PM UTC
BusinessMyriad Genetics and BeiGene Sign Agreement to Develop Companion Diagnostics for Use with BeiGene’s Novel PARP Inhibitor, BGB-290By Nasdaq OMXApr 6, 2017, 11:05 AM UTC
BusinessAchillion Announces Initiation of Patient Dosing in Phase 2 Study of ACH-4471 for Paroxysmal Nocturnal HemoglobinuriaBy Nasdaq OMXApr 6, 2017, 10:05 AM UTC
BusinessCascadian Therapeutics Highlights Preclinical Program Presentations at the American Association for Cancer Research Annual Meeting 2017By Nasdaq OMXApr 5, 2017, 12:00 PM UTC
BusinessNeothetics Announces Issuance by USPTO of Eighth Patent Directed to LIPO-202 Lead Clinical AssetBy Nasdaq OMXApr 5, 2017, 12:00 PM UTC
BusinessPivotal Study Results for Myriad’s myPath® Melanoma Test Highlighted In Two Additional Scientific PublicationsBy Nasdaq OMXApr 5, 2017, 11:05 AM UTC
